Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
Nippon India Mutual Fund

Nippon India Pharma Fund Direct-IDCW Reinvestment

NAV
returns change indicator
151.3241
as on 28 Mar 2024, 09:00 PM
1.7057(1.14%)
Last Change
loaderloader

Investment Performance

would have given a return of
1,10,871
star
1,21,647
star
1,69,519
star
1,74,191
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
74,191
Profit (absolute return)
74.19%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
8.08%
In the last 6 months
20.87%
In the last 1 year
58.12%
In the last 3 years
74.19%
In the last 5 years
192.14%
In the last 10 years
428.32%
Absolute Returns
CAGR

Scheme Riskometer

low
low
low to moderate
low to moderate
moderate
moderate
moderately high
moderately high
high
high
very high
very high
indicator
Investors understand that their principal will be at very high risk

Scheme Information

Nippon India Pharma Fund Direct-IDCW Reinvestment
Nippon India Pharma Fund Direct-IDCW Reinvestment
as of 29 Feb 2024, 05:30 AM
7,131.66 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 month.
0.94%
Expense Ratio
Plan
Dividend
0.52%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 month.
Scheme Document

Sectors Holding in this Mutual Fund

as on 29 Feb 2024
Sort By
Healthcare
97.94%
6,984.75 Cr
Others
2.06%
146.91 Cr

Companies Holding in this Mutual Fund

as on 29 Feb 2024
Sort By
Sun Pharmaceutical Industries Ltd.
14.51%
1,034.80 Cr
Lupin Ltd.
8.42%
600.49 Cr
Cipla Ltd.
6.43%
458.57 Cr
Apollo Hospitals Enterprise Ltd.
5.55%
395.81 Cr
Dr. Reddy's Laboratories Ltd.
4.95%
353.02 Cr
Others
60.14%
4,288.98 Cr
View All
View All

About Nippon India Pharma Fund Direct-IDCW Reinvestment

Nippon India Pharma Fund Direct-IDCW Reinvestment is a Equity mutual fund scheme from Nippon India Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Sailesh Raj Bhan. It has an AUM of ₹7,131.66 Crores and the latest NAV decalared is ₹151.324 as on 29 Mar 2024 at 6:02 pm.
Nippon India Pharma Fund Direct-IDCW Reinvestment scheme return performance in last 1 year is 58.12%, in last 3 years is 74.19% and 577.52% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.

Scheme Details

AUM:7,131.66 Cr
Category:Equity: Sectoral-Pharma
Launch Date:Invalid date
Fund Type:Open-End

AMC Information

Nippon India Mutual Fund
Nippon India Mutual Fund
View AMC Details
4,40,507.23 Cr
AUM
250
Schemes
Address
Address
4th Floor, Tower A, Peninsula Business Park,Ganapatrao Kadam Marg, Lower Parel (W),400013